| index | Title |
| 1 | Increased fatty acid synthase as a potential therapeutic target in multiple myeloma Author(s):Wei-qin WANG, Xiao-ying ZHAO, Hai-... Clicked:10855 Download:7113 Cited:22 <Full Text> Journal of Zhejiang University Science B 2008 Vol.9 No.6 P.441-447 DOI:10.1631/jzus.B0740640 |
| 2 | IgE myeloma with elevated level of serum CA125 Author(s):Man-ling WANG, Qiang HUANG, Tian-x... Clicked:8861 Download:4281 Cited:9 <Full Text> Journal of Zhejiang University Science B 2009 Vol.10 No.7 P.559-562 DOI:10.1631/jzus.B0820399 |
| 3 | Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma Author(s):He Huang, Heng-Wei Wu, Yong-Xian Hu Clicked:7515 Download:4431 Cited:0 <Full Text> <PPT> 2845 Journal of Zhejiang University Science B 2020 Vol.21 No.1 P.29-41 DOI:10.1631/jzus.B1900351 |
| 4 | Circular RNAs: typical biomarkers for bone-related diseases Author(s):Linghui HU, Wei WU, Jun ZOU Clicked:3432 Download:3127 Cited:0 <Full Text> <PPT> 1481 Journal of Zhejiang University Science B 2022 Vol.23 No.12 P.975-988 DOI:10.1631/jzus.B2200211 |
| 5 | High levels of serum IL-10 indicate disease progression, extramedullary involvement, and poor prognosis in ... Author(s):Xiaoyan YUE, Linlin HUANG, Yang YA... Clicked:3856 Download:3506 Cited:0 <Full Text> <PPT> 1819 Journal of Zhejiang University Science B 2022 Vol.23 No.11 P.968-974 DOI:10.1631/jzus.B2200277 |
| 6 | CUDC-101 as a dual-target inhibitor of EGFR and HDAC enhances the anti-myeloma effects of bortezomib by reg... Author(s):Wen CAO, Shunnan YAO, Anqi LI, Hao... Clicked:4335 Download:3012 Cited:0 <Full Text> <PPT> 1371 Journal of Zhejiang University Science B 2023 Vol.24 No.5 P.442-454 DOI:10.1631/jzus.B2200465 |
| 7 | Relapse mechanisms and disease management strategies after BCMA CAR-T therapy for multiple myeloma Author(s):Jiahao HE1,2,Clicked:260 Download:263 Cited:0 <Full Text> Journal of Zhejiang University Science B 1998 Vol.-1 No.-1 P. DOI:10.1631/jzus.B2500466 |